FIA
JNCE

FNY Investment Advisers’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

FNY Investment Advisers’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-15,000
Closed -$27K – 774
2023
Q1 		$27K Buy
+15,000
New +$27K 0.03% 237